InPharma CDMO R&D, precise thermal management is essential for reaction screening, route development, distillation, purification, crystallization, and scale-up from laboratory glass reactors to pilot-plant synthesis units. Chemie’s portfolio gives teams the flexibility to match fluid performance to each stage of development.E100supports ultra-low-temperature applications down to-115°C, making it suitable for jacketed glass reactors, constant-temperature baths, and rapid heating-cooling cycles, whileE181extends operation from-80 to 315°Cwith very low viscosity and even heat distribution for controlled thermal response.E200, E230, and E250provide low-temperature fluidity with operating windows of-85 to 230°C,-60 to 230°C, and-40 to 250°C, helping maintain reproducible reactor control and stable circulation in sensitive synthesis work. For wider thermal windows,E330reaches-49 to 315°Cwith4.04 mm²/s at 40°Cand a-68°C pour point, whileE350andTHTextend high-temperature capability to350°Cwith strong thermal stability and low system pressure characteristics.R1000andBPDfurther strengthen long-duration reactor, distillation, and heat-exchanger service with low-pour-point, high-stability performance, andARX/ARPbroaden portfolio flexibility for process-specific thermal design. Together,E100 / E181 / E200 / E230 / E250 / E330 / E350 / ARX / ARP / THT / R1000 / BPDhelp Pharma CDMO facilities improve batch consistency, protect product quality, and accelerate safe scale-up with greater operational efficiency.